title: Orthoclone OKT3 as first-line therapy in acute renal allograft rejection.
authors.affiliation: Department of Nephrology, Odense University Hospital, Denmark.
authors.forename: M
authors.initials: M
authors.lastname: Strate
authors.forename: K A
authors.initials: KA
authors.lastname: Jørgensen
authors.forename: N
authors.initials: N
authors.lastname: Rohr
authors.forename: A
authors.initials: A
authors.lastname: Elbirk
authors.forename: V
authors.initials: V
authors.lastname: Svendsen
authors.forename: S A
authors.initials: SA
authors.lastname: Birkeland
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3
chemical_list: D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3